Johnson & Johnson price target raised to $190 from $165 at Stifel

Stifel raised the firm’s price target on Johnson & Johnson to $190 from $165 and keeps a Hold rating on the shares after the company delivered above-consensus sales and EPS, offered up “bullish” commentary and “repeatedly emphasized their optimism” about the rest-of-2025 outlook and their confidence that the business is now in an “accelerated cycle of growth.”